These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7474323)

  • 1. [Lytic action of cefminox against slowly growing bacteria].
    Tsuruoka T; Miyata A; Yoshida T; Inouye S
    Jpn J Antibiot; 1995 Aug; 48(8):1003-8. PubMed ID: 7474323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bacteriological study of cefminox in the field of obstetrics and gynecology].
    Ninomiya K; Ohbayashi F; Hasegawa Y; Yoshimoto T
    Jpn J Antibiot; 1985 May; 38(5):1236-40. PubMed ID: 3930791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
    Matsuo K; Uete T
    Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A nationwide study of the antimicrobial susceptibility of clinical isolates of Escherichia coli in Japan].
    Igari J; Shitara M; Morimoto M; Shiga N; Kosakai N
    Jpn J Antibiot; 1986 Nov; 39(11):3094-109. PubMed ID: 3546776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cefminox concentration in tissues and clinical efficacy of cefminox in acute peritonitis].
    Nakamura T; Hashimoto I; Sawada Y; Mikami J; Yoshimoto M; Nishindai H; Nakanishi Y; Kasai Y
    Jpn J Antibiot; 1985 May; 38(5):1178-94. PubMed ID: 3930784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fundamental and clinical studies on cefminox in the field of pediatrics].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
    Jpn J Antibiot; 1985 Mar; 38(3):705-19. PubMed ID: 3897604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibacterial activity of cefminox in human urine].
    Goi H; Watanabe T; Hara T; Ishii T; Kazuno Y; Inouye S
    Jpn J Antibiot; 1988 Jan; 41(1):25-36. PubMed ID: 3367512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro susceptibility of Escherichia coli and Klebsiella sp. to antibiotics].
    Igari J; Shitara M; Shitara M; Yoshimoto K; Hayashi Y
    Jpn J Antibiot; 1990 Apr; 43(4):659-69. PubMed ID: 2199690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Susceptibilities of uropathogenic bacteria to ampicillin, cefazolin, cefmetazole and gentamicin. Nine-year survey of changing patterns of susceptibilities].
    Igari J; Shitara M; Shitara M; Yoshimoto K; Hayashi Y
    Jpn J Antibiot; 1990 Sep; 43(9):1530-7. PubMed ID: 2262960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nationwide study of the antimicrobial susceptibility of clinical isolates of Proteus group in Japan].
    Igari J; Shitara M; Morimoto M; Shiga N; Kosakai N
    Jpn J Antibiot; 1987 Apr; 40(4):823-42. PubMed ID: 3475483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative bactericidal and morphological effects of five cephamycins on cells of three gram-negative bacilli at decreasing drug concentrations.
    Goi H; Watanabe T; Miyauchi K; Kazuno Y; Inouye S
    Drugs Exp Clin Res; 1985; 11(11):771-80. PubMed ID: 3915467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Laboratory and clinical studies on cefminox].
    Sawae Y; Okada K; Kumagai Y
    Jpn J Antibiot; 1985 May; 38(5):1155-64. PubMed ID: 3930782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morphological alterations in Escherichia coli and Serratia marcescens induced by cefotetan (author's transl)].
    Saito M; Saito T; Yano K
    Jpn J Antibiot; 1982 Mar; 35(3):850-5. PubMed ID: 7047794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Laboratory and clinical studies of cefmetazole in serious infection by Staphylococcus (author's transl)].
    Motohiro T; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Onoda Y; Kusayanagi T; Tsuboi M; Toubo Y; Yamamoto M; Komatsu R; Tanaka C; Baba Y
    Jpn J Antibiot; 1982 Mar; 35(3):821-34. PubMed ID: 6954289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Timed bacteriostatic and bactericidal activities of cefmetazole against selected gram-negative bacteria].
    Masuda G; Young C; Negishi M; Watanabe T; Yamazaki E; Motegi K
    Jpn J Antibiot; 1982 Sep; 35(9):2288-92. PubMed ID: 6754988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on a new cephamycin preparation cefminox in the field of pediatrics].
    Sato H; Hirama Y; Narita A; Nakazawa S; Suzuki H; Matsumoto K; Tazoe K; Chikaoka H; Nakazawa S
    Jpn J Antibiot; 1985 Mar; 38(3):679-92. PubMed ID: 3839861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hospital and district differences in susceptibilities to antibiotics of main clinical isolates].
    Igari J; Shitara M; Shitara M; Yoshimoto K; Hayashi Y; Suzuki A; Kudo H; Hayasaka N; Toyoshima S; Yamazaki Y
    Jpn J Antibiot; 1990 Feb; 43(2):362-73. PubMed ID: 2194057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental and clinical studies of cefmetazole in the field of oral surgery].
    Minami Y; Taguchi M; Nanba R; Tsuto H; Yamamoto T; Ueda K; Tsushima T; Morihana T; Nagata K; Nakao K; Shimada K
    Jpn J Antibiot; 1982 May; 35(5):1308-21. PubMed ID: 6957626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of cefminox on bacterial flora in human adult feces].
    Motohiro T; Aramaki M; Tanaka K; Koga T; Shimada Y; Tomita S; Sakata Y; Fujimoto T; Nishiyama T; Kuda N
    Jpn J Antibiot; 1986 Apr; 39(4):909-57. PubMed ID: 3761549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Annual changes of sensitivities of Staphylococcus aureus to several antibiotics].
    Kosakai N; Mori M; Shitara M; Kudo M; Morimoto M
    Jpn J Antibiot; 1982 Aug; 35(8):1934-44. PubMed ID: 6961238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.